T. Rowe Price Associates »

Corbus Pharmaceuticals Hldgs shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.6M 193k 39.24

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Fiserv Comm Stk (FI)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Point72 Asset Management
Ikarian Capital
Vanguard Group
Adage Capital Partners GP
Octagon Capital Advisors
Citadel Advisors
Henderson Group
Millennium Management
Assenagon Asset Management
BlackRock
T. Rowe Price Associates
Barclays
Morgan Stanley
Boothbay Fund Management

View all funds holding Corbus Pharmaceuticals Hldgs